ZURICH, Sept 8 (Reuters) - The Swiss blue-chip SMI was seen opening little changed at 8,910 points on Friday, according to premarket indications by bank Julius Baer .
The following are some of the main factors expected to affect Swiss stocks.
Swiss utility BKW bought a small German nuclear services company on Thursday, joining firms including GE that are banking on rising revenue from the decommissioning of European nuclear plants.
A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumour, potentially helping doctors predict which patients may respond best to some immunotherapies.
* Leonteq appointed Chief Financial & Risk Officer Marco Amato its deputy CEO, widening Amato’s responsibilities.
* Credit Suisse: Harris Associates Investment Trust’s stake in the Swiss bank rose to 5.03 precent from a previous 4.97 percent according to Swiss bourse SIX.
* 5EL said the Swiss Takeover Board granted Highlight Finance Corp. an exemption from needing to make a public offer for the group after HFC for a short time between the group’s capital restructuring and subsequent capital increase in July controlled more than 80 percent of 5EL shares.
* PSP Swiss Property said it obtained a building permit for the “Orion” project in the west of Zurich, in which it expects to invest around 120 million Swiss francs ($127.06 million).
* The Swiss unemployment rate remained steady at a non-seasonally adjusted 3.0 percent in August, the State Secretariat for Economic Affairs said. ($1 = 0.9444 Swiss francs) (Reporting by Zurich newsroom)